Late night eating and sleep habits damage gut health, increase metabolic disease risk

https://www.news-medical.net/news/20261109/Late-night-eating-and-sleep-habits-damage-gut-health-increase-metabolic-disease-risk.aspx A new study led by UTHealth Houston identified a link between late-night eating and sleeping habits, gut health, and metabolic disease, offering new insights into why some individuals with obesity may face risk of inflammation and related health problems. The findings were published in iScience and led by Faraz Bishehsari, MD, PhD, professor and director of the Gastroenterology Research Center in the Department of Internal Medicine at McGovern Medical School at UTHealth Houston

Most eligible teens miss out on advanced obesity treatments

https://www.news-medical.net/news/20261109/Most-eligible-teens-miss-out-on-advanced-obesity-treatments.aspx Despite the arrival of powerful new anti-obesity medications and growing evidence supporting weight-loss surgery for adolescents, the vast majority of eligible teens are receiving neither treatment, according to a new study from Ann & Robert H. Lurie Children's Hospital of Chicago published in JAMA Pediatrics.

A child's sex may change how early sugar intake relates to body fat

https://www.news-medical.net/news/20261109/A-childs-sex-may-change-how-early-sugar-intake-relates-to-body-fat.aspx Could the timing of sugar exposure matter as much as the amount consumed? Researchers examined diets from pregnancy through toddlerhood to investigate how early nutrition relates to children's developing body composition. In a recent longitudinal study published on the medRxiv preprint* server, researchers evaluated whether a child's sex modified associations between early dietary sugar exposure and body composition. The investigators analyzed dietary and body-composition data from 130 mother-child dyads across the first 1,000 days (from conception to approximately 24 months) to examine how added sugars and fructose intake during pregnancy and early childhood related to body fat at two years.

Your Instagram photos may reveal more about loneliness than you think

https://www.news-medical.net/news/20261109/Your-Instagram-photos-may-reveal-more-about-loneliness-than-you-think.aspx From late-night posts to facial expressions in profile pictures, researchers examined whether everyday Instagram habits could offer a window into an often-hidden aspect of mental health. Research suggests that loneliness is associated with an increased risk of early death comparable to that associated with smoking. In a recent study published in the journal npj Mental Health Research, scientists at the University of California, San Diego, La Jolla, CA, USA, tested whether Instagram behavior among American college students reveals several distinct forms of loneliness.

Drinking 2–3 cups of coffee a day? A study of 495,000 adults links it to lower AF risk

https://www.news-medical.net/news/20261109/Drinking-2e280933-cups-of-coffee-a-day-A-study-of-495000-adults-links-it-to-lower-AF-risk.aspx Could your daily coffee or tea habit influence your heart rhythm? A 13-year study involving nearly half a million UK adults examines how different consumption levels relate to atrial fibrillation risk, raising fresh questions about two of the world's most popular beverages. In a recent study published in the journal Food & Nutrition Research, researchers investigated associations between tea and coffee intake and the risk of atrial fibrillation (AF). The findings linked coffee consumption to a modestly lower AF risk, particularly at 2–3 cups daily, while tea results were less consistent.

Why are some patients lying to their doctors to get antibiotics?

https://www.news-medical.net/news/20261110/Why-are-some-patients-lying-to-their-doctors-to-get-antibiotics.aspx From feeling ignored by doctors to believing antibiotics are the only answer, new research reveals why some patients bend the truth to get prescriptions, and what this could mean for antibiotic resistance. A recent study in the journal JAMA Network Open reports that in a survey of US adults, nearly 28% said they had at some point misrepresented their symptoms to clinicians to obtain antibiotics. Lower awareness of antibiotic risks and the dangers of antimicrobial resistance were associated with higher odds of such misrepresentation.

Qureight’s fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

https://www.news-medical.net/news/20261110/Qureighte28099s-fibrosis-imaging-biomarker-selected-by-Contineum-Therapeutics-as-a-secondary-endpoint-in-Phase-2-PROPEL-IPF-clinical-trial.aspx Qureight, an end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, and Contineum Therapeutics, Inc. (Contineum), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today announced that Qureight’s Fibr8™ quantitative imaging biomarker is being used as a secondary endpoint in Contineum’s PROPEL-IPF Phase 2 clinical trial examining the safety and efficacy of PIPE-791, Contineum’s lead drug candidate, in idiopathic pulmonary fibrosis (IPF) patients.